System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Live1m

Terminal Asset View

stockNASDAQ

ACTU

$2.56+0.39%

Actuate Therapeutics Inc. - Common stock

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

10Neutral

Live Analysis Active

Company Mission

Actuate Therapeutics creates experimental medicines designed to fight cancer by targeting specific proteins that help tumors grow. The company works with research partners and investors to fund clinical trials, hoping to eventually sell successful drugs to pharmaceutical companies or directly to healthcare providers. Their value comes from developing treatments that could help cancer patients while generating revenue through partnerships and potential future drug sales.

ACT

Industry Context

Actuate Therapeutics operates in the biotechnology industry, which focuses on developing medical treatments using biological processes. This sector is known for high research costs and significant price swings when companies announce clinical trial results or receive regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

25Matrix

Market Momentum

23.0— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

2.2x— Normal Volume

Today's Change

0.39%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ACTU across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:00 PM UTC

As-of 03-14-2026 19:45 UTC

Develops cancer drugs that target specific tumor proteins and makes money by licensing these treatments to pharmaceutical companies.

Weekly price swings are getting smaller, suggesting the Stock is coiling tighter before a potential larger move.

Biotech sector volatility often increases during clinical trial announcements, which could impact this company's Stock price.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...